Characterizing Sleep Among Long-term Survivors of Childhood Cancer

Recruiting

• Conditions: ALL, Adult; CNS Tumor; Solid Tumor
• Interventions: Diagnostic Test: CNS Vital Signs (Thinking) Testing; Other: Neurocognitive (Thinking) Testing; Other: Health Questionnaires, Sleep Surveys & Sleep Diary; Diagnostic Test: Echocardiography/EKG; Diagnostic Test: Pulmonary Function; Device: Remote Polysomnography; Diagnostic Test: Physical Function

• Registration Number: NCT05480904
• Lead Sponsor: St. Jude Children's Research Hospital

Brief Summary

The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors.

Primary Objective

The primary aim of this protocol is to estimate the prevalence of various sleep disorders among long-term survivors of childhood ALL, CNS tumors, and non- CNS solid tumors.

Exploratory Objective

The exploratory objective of the study is to explore associations between the prevalence of sleep disorders and clinical outcomes collected in SJLIFE.

Detailed Description

A cross-sectional pilot study that will enroll participants for on-campus or remote study activities. The investigators anticipate a targeted evaluable accrual of 120, 40 within each of the three groups identified above. The plan is to employ remote polysomnography and surveys to assess patterns of sleep disorders. These assessments could be done in the homes of survivors or during campus visits.

Study Timeline

• Study First Submitted: 2022-07-19
• Study First Submitted QC: 2022-07-27
• Study First Posted: 2022-07-29
• Study Start: 2023-04-17
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-15
• Last Update Posted: 2025-05-18
• Primary Completion: 2026-07
• Study Completion: 2027-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Participant in SJLIFE and > 5 years from diagnosis.
• >18 years of age at time of enrollment.
• Diagnosed with ALL (treated with CRT or chemotherapy only) or CNS tumors (posterior fossa tumors or supratentorial tumors) or non-CNS solid tumors (with abdominal or chest radiation or bilateral retinoblastoma survivors).
• Participant was less than 21 years of age at time of diagnosis.
• Speaks and understands English (polysomnography device speaks to patients only in English).
• Remote participant must have Wi-Fi access

Exclusion Criteria

• Estimated intelligence score <80.
• Currently prescribed an intervention for a sleep disorder.
• Survivor of craniopharyngioma.
• Survivor of Hodgkin Lymphoma.
• Relapsed or treated with hematopoietic stem cell therapy.
• Brain injury unrelated to cancer diagnosis or therapy.
• Pulmonary injury unrelated to cancer diagnosis or therapy.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
On campus	Physical Function	SJLIFE Study Campus Visit
On campus	Health Questionnaires, Sleep Surveys & Sleep Diary	SJLIFE Study Campus Visit
On campus	Echocardiography/EKG	SJLIFE Study Campus Visit
Remote	CNS Vital Signs (Thinking) Testing	SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors
Remote	Health Questionnaires, Sleep Surveys & Sleep Diary	SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors
On campus	Neurocognitive (Thinking) Testing	SJLIFE Study Campus Visit
On campus	Remote Polysomnography	SJLIFE Study Campus Visit
Remote	Remote Polysomnography	SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors
On campus	Pulmonary Function	SJLIFE Study Campus Visit

Primary Outcome Measures

Name	Time	Method
Insomnia Severity Index (ISI)	Baseline	ISI is a seven-item questionnaire that looks at symptoms of clinical insomnia. The ISI assesses insomnia symptoms over the past 14 days and has demonstrated good reliability and validity. The total ISI score ranges from 0 to 28, with scores \< 8 indicating no significant insomnia.
CSALTS Pain Survey	Baseline for 2 nights	The 7-item pain survey will include pain interference questions from the SJLIFE Behavioral Survey and one pain intensity question. The six items that measures amount of pain interference in daily activities in last 7 days is measured from "not at all" to "very much." The pain intensity question is measured 1-10 with 10 "worst imaginable pain."
Circadian Type Inventory (CTI)	Baseline	CTI is an 11-item questionnaire that looks at rigidity/flexibility of sleeping habits and ability/inability to overcome drowsiness (i.e., circadian rhythm disorders). Respondents use a 5-item, Likert-type scale to answer questions regarding their sleep habits and preferences. Scales range from 1 ("almost never") to 5 ("almost always"). Higher scores on the rigidity subscales indicate a greater flexibility in circadian rhythm, while lower scores on the overcoming-drowsiness subscale indicate a greater ability to manage on less sleep.
Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT)	Baseline	fatigue scale is a short 13-item tool that provides a single measure of an individual's level of fatigue during a usual day.
CSALTS Sleep Survey	Baseline	CSALTS Sleep Survey incorporating Epworth Sleepiness Scale (EPS) and Pittsburg Sleep Quality Index (PSQI) The CSALTS Sleep Survey assesses sleep quality, patterns, and daytime sleepiness. It incorporates 19 questions from the PSQI and 8 questions of the ESS. The PSQI and ESS total scores will be reported.
Morningness-Eveningness Questionnaire (MEQ)	Baseline	The MEQ is a 19-question measure that assesses the degree to which respondents are active and alert at certain times of the day. Each item is rated using a Likert-type scale with lower scales reflecting a more evening-type characterization of alertness. Global scores range from 16 to 86 and these values are used to define 'definitely morning type' (70-86), 'moderately morning type' (59-69), 'neither type' (42-58), 'moderately evening type' (31-41), and 'definitely evening type' (16-30).
Polysomnography Evaluation (Sleep Profiler PSG2 or WatchPAT)	Baseline	The Sleep Profiler PSG2 measures brain waves during sleep, blood oxygen levels, heart rate, and breathing and will measure different patterns of sleep stages. Two nights of data collection will be requested though one night will be sufficient if the participant sleeps at least 4 hours. The apnea hypopnea index and sleep efficiency scores will be reported.; The WatchPAT device assesses sleep timing, sleep staging, and sleep apnea events via a device worn on the wrist that measures limb movement, peripheral arterial tone and connects to an EKG electrode. Two nights of data collection will be requested though one night will be sufficient if the participant sleeps at least 4 hours. The apnea hypopnea index and sleep efficiency scores will be reported

Secondary Outcome Measures

Name	Time	Method
Memory-California Verbal Learning Test 2nd Ed.	Baseline	Orally administered test of verbal learning, short-term and long-term verbal free-recall memory, requiring participant to learn and remember a list of words, measured in T-score and z-scores.
Executive Functions -Trail Making Test or CNS-VS Shifting Attention Test	Baseline	The Trail Making Test is a timed task that requires a participant to shift his/her attention adaptively and flexibly. Considered a measure of cognitive flexibility. Standard score for Trail Making Letter-Word Switching will be reported.; Shifting Attention Test (SAT) measure cognitive flexibility with a single standard score.
Executive Functions- Verbal Fluency Test Controlled Oral Word Association (COWA) or CNS-VS Stroop Test	Baseline	This is a task of cognitive/verbal fluency. Participants are given a letter and must say as many words that start with that letter within 60 seconds. A single age-adjusted z-score will be reported.; Stroop Test (ST) measures cognitive control and fluency with a single standard score
Executive Functions -Digit Span Backward	Baseline	Digit Span Backward: Digit Span Backward (DSB), from the Digit Span subtest on the WAIS-IV, is a measure of working memory. The number of digits recalled in the longest span is converted to a standard score using age-based norms. Considered a process score on the WAIS-IV DSB is found to have acceptable reliability and validity parameters.
Sustained Attention -Conners Continuous Performance Test 3rd Ed or CNS-VS CPT.	Baseline	Computerized test of omissions, variability, and reaction time, requiring participants to respond to letter stimuli on the screen quickly and accurately, while avoiding targets. These three scores will be reported in T scores.

Trial Locations

Locations (1)

St. Jude Children's Research Hospital; 🇺🇸 Memphis, Tennessee, United States